Fujifilm Diosynth breaks ground on 0M biotech plant expansion near Texas A&M

A $300 million expansion of medical manufacturing facility near Texas A&M University could help to further bolster efforts to turn Texas into a bio...

October 26, 2022
3:36 PM

A $300 million expansion of medical manufacturing facility near Texas A&M University could help to further bolster efforts to turn Texas into a biotech hub. Fujifilm Diosynth, maker of the Noravax COVID-19 vaccine and medical devices, broke ground this week on a expansion of its College Station campus that will double its advanced therapy and vaccine manufacturing capacity in the U.S. once complete in 2024. Located about 100 miles northwest of Houston, the College Station plant will become one of the largest single-use medical device manufacturing campuses in North America once the expansion is complete, according to Fujifilm Diosynth.

Marissa Luck